Maykin Ho - Venture Partner @ Qiming Venture Partners

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

126,085

Primary Job Title Venture Partner
Primary Organization
Qiming Venture Partners

Location Hong Kong, Hong Kong Island, Hong Kong
Regions Asia-Pacific (APAC)
Gender Female

LinkedIn View on LinkedIn

Maykin Ho is based out of New York, New York and is the Board Member of Neumora. Maykin previously worked at Goldman Sachs as an advisory director in healthcare investment banking. Maykin Ho attended the Harvard Medical School.

Jobs

Number of Current Jobs

Number of Past Jobs

Maykin Ho

is the

Venture Partner

Qiming Venture Partners

. Additionally,

Maykin Ho

has had

past jobs including

Advisory director, healthcare investment banking

Goldman Sachs

Qiming Venture Partners Venture PartnerJul 2015

Organization Name	Title At Company	Start Date	End Date
Goldman Sachs	Advisory director, healthcare investment banking	2010	Feb 2015
Goldman Sachs	Senior biotechnology analyst	1992	2010
Dupont	Director, Strategic Planning and Licensing	—	—
Goldman Sachs	Partner	—	—
Goldman Sachs	Co-head of healthcare for global investment research	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Maykin Ho

holds

board and advisor roles including

Board Member

Neumora Therapeutics

Board Member

Grail

, and

Board Member

Agios Pharmaceuticals

Neumora Therapeutics Board MemberApr 2021
Grail Board MemberMay 2019
Agios Pharmaceuticals Board MemberJun 2015
Aaron Diamond AIDS Research Center Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Asia Seed Stage Investors	1,486
Investors Active in Hong Kong Island	10,355
SoftBank Alumni Founded Companies	92,211
Asia Investors with Funds Raised in 2019	25,055
Asia Investors with Funds Raised in 2016	56,942
Private Equity Stage Investors with Investments in Asia-Pacific (APAC)	4,685
Asia Investors with Funds Raised in 2022	26,004
Late Stage Venture Investors with Investments in Hong Kong, Hong Kong Island	31,839
Asia Investors with Funds Raised in 2023	19,810
Private Equity Stage Investors with Investments in Asia	3,807